LEAH BRINCEFIELD-WERMER: Open Payments
NPI 1437783719 · NEW HAVEN, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$301 in 18 payments from 8 companies in 2025. Trend: 2023 $472 · 2024 $258 · 2025 $301
Food & beverage: $301
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $82 |
| Novo Nordisk Inc | 4 | $75 |
| Axsome Therapeutics, Inc. | 2 | $33 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
| Lilly USA, LLC | 2 | $28 |
| Exact Sciences Corporation | 1 | $19 |
| Corcept Therapeutics | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
Products named: QULIPTA, Ozempic, Wegovy, Auvelity, MOUNJARO, The Cologuard Plus Collection Kit, VRAYLAR, Korlym.
Industry payments across IN — which companies pay providers there.
